Equifax Inc.

Based on a comprehensive review of Equifax (EFX), the stock presents a challenging profile for new investment at this time.

From a technical perspective, the stock is showing significant weakness, with sharp recent declines and high volatility, suggesting ongoing downward pressure. Fundamentally, while revenue is stable, there are clear concerns with a collapsing gross profit margin and potential liquidity constraints indicated by the low current ratio. The valuation appears demanding, with premium multiples like a TTM PE of 47.6 and a high PEG ratio, implying the stock's price already reflects lofty growth expectations that may be difficult to achieve given the recent operational pressures.

Recommendation: HOLD / MONITOR

Currently, the combination of technical weakness, concerning fundamental trends, and a rich valuation creates significant headwinds. Investors should wait for signs of stabilization in the company's profit margins and a more compelling valuation before considering a position. The current risk-reward profile does not justify a buy recommendation.

RockFlow Model Forecast: Three Scenarios for 2026

Based on the comprehensive analysis provided, here is the 12-month outlook for Equifax (EFX):

12-Month Outlook for EFX

The outlook for EFX over the next year is cautious, with the stock likely to face headwinds as it works to stabilize its operations. Key catalysts for a positive reassessment would be demonstrating a successful reversal of the collapsing gross profit margins and evidence that its current growth strategy can justify its premium valuation. The primary risks are the persistence of operational pressures, an inability to improve profitability, and the high likelihood of volatility due to its rich valuation multiples (TTM PE of 47.6) if growth expectations are not met. Without a specific analyst target, the near-term price action is expected to be challenging, and investors should monitor for a more attractive entry point, aligning with the HOLD / MONITOR recommendation.

Wall Street Consensus

Most Wall Street analysts are optimistic about Equifax Inc.'s 12-month outlook, with consensus target around $192.80, indicating expected upside potential.

Overall, EFX has investment potential but also faces challenges. Here are key factors to weigh before investing.

EFX has demonstrated notably weak performance with substantial recent declines and significant underperformance relative to the broader market.

The stock has declined sharply over both short-term periods, with a 12.27% drop over one month and 7.67% over three months, substantially underperforming the market by 7.72% during the latter period. This pronounced weakness, coupled with a high beta of 1.559, indicates heightened volatility and significant downside pressure recently.

Currently trading at $192.80, EFX sits approximately 31% above its 52-week low but remains 31% below its 52-week high, positioning it closer to the midpoint of its annual range. Given the steep 37.6% maximum drawdown and recent sharp declines, the stock appears oversold in the near term despite its considerable distance from recent peaks.

Revenue & Profitability EFX demonstrated stable revenue growth with Q4 2025 revenue of $1.55 billion, slightly up from $1.54 billion in Q3. However, gross profit ratio declined significantly from 57.1% to 10.9%, primarily due to a substantial increase in cost of revenue. Net profit margin improved to 11.3% from 10.4% in Q3, indicating better cost management despite gross margin pressure.

Financial Health The company maintains a moderate debt level with a debt-to-equity ratio of 1.11 and total debt to capitalization of 52.5%. Interest coverage remains adequate at 5.25x, while the cash flow to debt ratio of 0.09 suggests limited cash generation relative to obligations. Current ratio of 0.60 indicates potential liquidity constraints in meeting short-term liabilities.

Operational Efficiency EFX shows modest operational efficiency with ROE of 3.8% and asset turnover of 0.13, reflecting moderate returns on capital deployment. The company maintains strong cash flow generation with operating cash flow per share of $3.88, though fixed asset turnover of 0.43 indicates room for improvement in asset utilization efficiency.

Valuation Level: Equifax's valuation appears significantly elevated based on multiple metrics. With a TTM PE of 47.6 and forward PE of 37.5, the stock trades at a premium multiple that suggests high growth expectations from the market. The extremely high EV/EBITDA of 66.9 and elevated PEG ratio of 3.2 further indicate the stock may be overvalued relative to its current earnings power and growth trajectory.

Peer Comparison: Without specific industry average data for comparison, a comprehensive peer analysis cannot be conducted. However, given the substantial premiums across all valuation metrics shown, Equifax's valuation likely exceeds typical industry norms. Investors would benefit from comparing these figures against professional services or data analytics sector averages for proper context.

Volatility Risk: EFX exhibits high volatility, with a beta of 1.559 indicating it is roughly 56% more volatile than the broader market. This elevated sensitivity was confirmed by the significant 1-year maximum drawdown of -37.6%, underscoring the stock's potential for substantial price declines during market downturns.

Other Risks: While the absence of notable short interest suggests limited speculative pressure or immediate downside sentiment, the broader risk profile must still consider EFX's specific industry challenges and liquidity. Factors such as regulatory changes affecting the credit reporting sector and overall trading volume should be carefully evaluated.